Mindfulness-based stress reduction for overweight/obese women with and without polycystic ovary syndrome: Design and methods of a pilot randomized controlled trial

Nazia Raja-Khan, Katrina Agito, Julie Shah, Christy M. Stetter, Theresa S. Gustafson, Holly Socolow, Allen R. Kunselman, Diane K. Reibel, Richard S. Legro

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Introduction: Mindfulness-based stress reduction (MBSR) may be beneficial for overweight/obese women, including women with polycystic ovary syndrome (PCOS), as it has been shown to reduce psychological distress and improve quality of life in other patient populations. Preliminary studies suggest that MBSR may also have salutary effects on blood pressure and blood glucose. This paper describes the design and methods of an ongoing pilot randomized controlled trial evaluating the feasibility and effects of MBSR in PCOS and non-PCOS women who are overweight or obese (. NCT01464398). Methods and design: Eighty six (86) women with body mass index≥25kg/m2, including 31 women with PCOS, have been randomized to 8weeks of MBSR or health education control, and followed for 16weeks. The primary outcome is mindfulness assessed with the Toronto Mindfulness Scale. Secondary outcomes include measures of blood pressure, blood glucose, quality of life, anxiety and depression. Discussion: Our overall hypothesis is that MBSR will increase mindfulness and ultimately lead to favorable changes in blood pressure, blood glucose, psychological distress and quality of life in PCOS and non-PCOS women. This would support the integration of MBSR with conventional medical treatments to reduce psychological distress, cardiovascular disease and diabetes in PCOS and non-PCOS women who are overweight or obese.

Original languageEnglish (US)
Pages (from-to)287-297
Number of pages11
JournalContemporary Clinical Trials
Volume41
DOIs
StatePublished - Mar 1 2015

Fingerprint

Mindfulness
Polycystic Ovary Syndrome
Randomized Controlled Trials
Blood Glucose
Ovary
Quality of Life
Psychology
Blood Pressure
Health Education
Cardiovascular Diseases
Anxiety
Outcome Assessment (Health Care)
Depression

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this

@article{6b620e91d39d45bab92512453b2d5dd4,
title = "Mindfulness-based stress reduction for overweight/obese women with and without polycystic ovary syndrome: Design and methods of a pilot randomized controlled trial",
abstract = "Introduction: Mindfulness-based stress reduction (MBSR) may be beneficial for overweight/obese women, including women with polycystic ovary syndrome (PCOS), as it has been shown to reduce psychological distress and improve quality of life in other patient populations. Preliminary studies suggest that MBSR may also have salutary effects on blood pressure and blood glucose. This paper describes the design and methods of an ongoing pilot randomized controlled trial evaluating the feasibility and effects of MBSR in PCOS and non-PCOS women who are overweight or obese (. NCT01464398). Methods and design: Eighty six (86) women with body mass index≥25kg/m2, including 31 women with PCOS, have been randomized to 8weeks of MBSR or health education control, and followed for 16weeks. The primary outcome is mindfulness assessed with the Toronto Mindfulness Scale. Secondary outcomes include measures of blood pressure, blood glucose, quality of life, anxiety and depression. Discussion: Our overall hypothesis is that MBSR will increase mindfulness and ultimately lead to favorable changes in blood pressure, blood glucose, psychological distress and quality of life in PCOS and non-PCOS women. This would support the integration of MBSR with conventional medical treatments to reduce psychological distress, cardiovascular disease and diabetes in PCOS and non-PCOS women who are overweight or obese.",
author = "Nazia Raja-Khan and Katrina Agito and Julie Shah and Stetter, {Christy M.} and Gustafson, {Theresa S.} and Holly Socolow and Kunselman, {Allen R.} and Reibel, {Diane K.} and Legro, {Richard S.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.cct.2015.01.021",
language = "English (US)",
volume = "41",
pages = "287--297",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",

}

Mindfulness-based stress reduction for overweight/obese women with and without polycystic ovary syndrome : Design and methods of a pilot randomized controlled trial. / Raja-Khan, Nazia; Agito, Katrina; Shah, Julie; Stetter, Christy M.; Gustafson, Theresa S.; Socolow, Holly; Kunselman, Allen R.; Reibel, Diane K.; Legro, Richard S.

In: Contemporary Clinical Trials, Vol. 41, 01.03.2015, p. 287-297.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mindfulness-based stress reduction for overweight/obese women with and without polycystic ovary syndrome

T2 - Design and methods of a pilot randomized controlled trial

AU - Raja-Khan, Nazia

AU - Agito, Katrina

AU - Shah, Julie

AU - Stetter, Christy M.

AU - Gustafson, Theresa S.

AU - Socolow, Holly

AU - Kunselman, Allen R.

AU - Reibel, Diane K.

AU - Legro, Richard S.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Introduction: Mindfulness-based stress reduction (MBSR) may be beneficial for overweight/obese women, including women with polycystic ovary syndrome (PCOS), as it has been shown to reduce psychological distress and improve quality of life in other patient populations. Preliminary studies suggest that MBSR may also have salutary effects on blood pressure and blood glucose. This paper describes the design and methods of an ongoing pilot randomized controlled trial evaluating the feasibility and effects of MBSR in PCOS and non-PCOS women who are overweight or obese (. NCT01464398). Methods and design: Eighty six (86) women with body mass index≥25kg/m2, including 31 women with PCOS, have been randomized to 8weeks of MBSR or health education control, and followed for 16weeks. The primary outcome is mindfulness assessed with the Toronto Mindfulness Scale. Secondary outcomes include measures of blood pressure, blood glucose, quality of life, anxiety and depression. Discussion: Our overall hypothesis is that MBSR will increase mindfulness and ultimately lead to favorable changes in blood pressure, blood glucose, psychological distress and quality of life in PCOS and non-PCOS women. This would support the integration of MBSR with conventional medical treatments to reduce psychological distress, cardiovascular disease and diabetes in PCOS and non-PCOS women who are overweight or obese.

AB - Introduction: Mindfulness-based stress reduction (MBSR) may be beneficial for overweight/obese women, including women with polycystic ovary syndrome (PCOS), as it has been shown to reduce psychological distress and improve quality of life in other patient populations. Preliminary studies suggest that MBSR may also have salutary effects on blood pressure and blood glucose. This paper describes the design and methods of an ongoing pilot randomized controlled trial evaluating the feasibility and effects of MBSR in PCOS and non-PCOS women who are overweight or obese (. NCT01464398). Methods and design: Eighty six (86) women with body mass index≥25kg/m2, including 31 women with PCOS, have been randomized to 8weeks of MBSR or health education control, and followed for 16weeks. The primary outcome is mindfulness assessed with the Toronto Mindfulness Scale. Secondary outcomes include measures of blood pressure, blood glucose, quality of life, anxiety and depression. Discussion: Our overall hypothesis is that MBSR will increase mindfulness and ultimately lead to favorable changes in blood pressure, blood glucose, psychological distress and quality of life in PCOS and non-PCOS women. This would support the integration of MBSR with conventional medical treatments to reduce psychological distress, cardiovascular disease and diabetes in PCOS and non-PCOS women who are overweight or obese.

UR - http://www.scopus.com/inward/record.url?scp=84924069776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924069776&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2015.01.021

DO - 10.1016/j.cct.2015.01.021

M3 - Article

C2 - 25662105

AN - SCOPUS:84924069776

VL - 41

SP - 287

EP - 297

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

ER -